We are live on !
Find out more
KLP
Kent Lake PR Portfolio holdings
AUM
$198M
Turnover
60.34%
1-Year Est. Return
5.21%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+5.21%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
-$28.8M
(-13%)
Cap. Flow
-$32.1M
Cap. Flow % of AUM
Cap. Flow %
-16.21%
Top 10 Holdings %
Top 10 Hldgs %
52.04%
Holding
58
New
19
Increased
8
Reduced
14
Closed
16
Avg Time Held
Equity + Options
0.4
years
Top 10 Avg Time Held
Equity + Options
0.4
years
Top 20 Avg Time Held
Equity + Options
0.5
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Integra LifeSciences
IART
|
+$10.3M |
| 2 |
Pennant Group
PNTG
|
+$9.8M |
| 3 |
Mesa Laboratories
MLAB
|
+$9.7M |
| 4 |
CareDx
CDNA
|
+$7.84M |
| 5 |
Upwork
UPWK
|
+$7.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Concentrix
CNXC
|
+$14.1M |
| 2 |
NCR Voyix
VYX
|
+$9.9M |
| 3 |
Quanterix
QTRX
|
+$6.91M |
| 4 |
Myriad Genetics
MYGN
|
+$6.64M |
| 5 |
Groupon
GRPN
|
+$5.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.34% |
| 2 | Technology | 25.31% |
| 3 | Communication Services | 6.03% |
| 4 | Consumer Discretionary | 4.78% |
| 5 | Financials | 3.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Pennant Group
PNTG
$1.42B
| $21.8M | 11.02% |
865,000
+399,900
| +86% | +$9.8M |
2024 Q3
4 quarters
|
|
|
2
Integra LifeSciences
IART
$1.05B
| $10.8M | 5.44% |
+752,086
| New | +$10.3M |
2025 Q3
0 quarters
|
|
3
Neuropace
NPCE
$439M
| $10.3M | 5.21% |
1,000,000
+75,000
| +8% | +$707K |
2024 Q3
4 quarters
|
|
|
4
NCR Voyix
VYX
$1.07B
| $9.41M | 4.75% |
750,000
-750,000
| -50% | -$9.9M |
2024 Q3
4 quarters
|
|
|
5
Upwork
UPWK
$1.06B
| $9.28M | 4.69% |
+500,000
| New | +$7.45M |
2025 Q3
0 quarters
|
|
|
6
Mesa Laboratories
MLAB
$693M
| $9.01M | 4.55% |
+134,516
| New | +$9.7M |
2025 Q3
0 quarters
|
|
7
InnovAge Holding
INNV
$1.21B
| $8.98M | 4.53% |
1,739,685
+42,649
| +3% | +$172K |
2024 Q3
4 quarters
|
|
8
DELISTED
Enhabit
EHAB
| $8.65M | 4.37% |
1,079,607
-120,393
| -10% | -$905K |
2024 Q3
4 quarters
|
|
|
9
CareDx
CDNA
$3.47B
| $8M | 4.04% |
+550,000
| New | +$7.84M |
2025 Q3
0 quarters
|
|
10
Green Dot
GDOT
$690M
| $6.8M | 3.43% |
+506,303
| New | +$6.25M |
2025 Q3
0 quarters
|
|
11
Flywire
FLYW
$2.24B
| $6.77M | 3.42% |
500,000
+85,594
| +21% | +$1.05M |
2025 Q2
1 quarter
|
|
12
Bioventus
BVS
$921M
| $6.69M | 3.38% |
1,000,200
+650,164
| +186% | +$4.51M |
2025 Q2
1 quarter
|
|
13
Consensus Cloud Solutions
CCSI
$654M
| $5.87M | 2.97% |
200,000
-50,000
| -20% | -$1.24M |
2025 Q1
2 quarters
|
|
14
Enviri
NVRI
$547M
| $5.71M | 2.88% |
450,000
-50,000
| -10% | -$517K |
2025 Q2
1 quarter
|
|
|
15
Quanterix
QTRX
$132M
| $5.44M | 2.75% |
1,001,000
-1,300,000
| -56% | -$6.91M |
2024 Q3
4 quarters
|
|
16
Teleflex
TFX
$5.52B
| $4.89M | 2.47% |
+40,000
| New | +$4.85M |
2025 Q3
0 quarters
|
|
17
Viemed Healthcare
VMD
$365M
| $4.75M | 2.4% |
700,000
-479,605
| -41% | -$3.25M |
2024 Q3
4 quarters
|
|
18
Citi Trends
CTRN
$407M
| $4.65M | 2.35% |
150,000
-60,290
| -29% | -$1.95M |
2024 Q3
4 quarters
|
|
19
Stitch Fix
SFIX
$354M
| $4.35M | 2.2% |
+1,000,000
| New | +$4.94M |
2025 Q3
0 quarters
|
|
20
Inogen
INGN
$174M
| $4.08M | 2.06% |
500,000
-561,294
| -53% | -$4.2M |
2024 Q3
4 quarters
|
|
21
Universal Electronics
UEIC
$69.6M
| $4.04M | 2.04% |
867,400
-393,242
| -31% | -$2.16M |
2024 Q3
4 quarters
|
|
22
Mitek Systems
MITK
$753M
| $3.91M | 1.97% |
400,000
-500,000
| -56% | -$4.91M |
2024 Q3
4 quarters
|
|
23
PDF Solutions
PDFS
$1.74B
| $3.87M | 1.96% |
150,000
+7,779
| +5% | +$170K |
2025 Q2
1 quarter
|
|
24
SI-BONE Inc
SIBN
$882M
| $3.68M | 1.86% |
250,000
+43,755
| +21% | +$714K |
2024 Q3
4 quarters
|
|
25
Tandem Diabetes Care
TNDM
$1.14B
| $3.04M | 1.53% |
+250,000
| New | +$3.38M |
2025 Q3
0 quarters
|
|
Similar funds
TC
DLHL
RHI
AWM
CC
WTFG
KAH
APC
Kent Lake PR's Q3 2025 Portfolio in Review
As of Q3 2025, Kent Lake PR held 58 positions worth $198M, down 13% from $227M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Kent Lake PR withdrew a net $32.1M in Q3 2025, closing 16 positions and reducing 14 holdings. Its most notable exit was Concentrix, an estimated $14.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 49% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Kent Lake PR opened a new position in Integra LifeSciences worth $10.8M.
- Kent Lake PR's largest Q3 2025 buy was Integra LifeSciences: 752,086 shares worth $10.8M.
- Kent Lake PR added most to Pennant Group in Q3 2025, an estimated $9.8M increase.
- Kent Lake PR's biggest Q3 2025 reduction was NCR Voyix, cutting an estimated $9.9M.
- Kent Lake PR fully exited Concentrix in Q3 2025, selling an estimated $14.1M.
- Kent Lake PR's ten largest holdings make up 52% of its $198M portfolio in Q3 2025.
- Kent Lake PR opened 19 new positions and closed 16 in Q3 2025.
- Kent Lake PR's portfolio value fell 13% quarter-over-quarter to $198M.
Based on Kent Lake PR's 13F filing for Q3 2025, filed 14 Nov 2025.